Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.

Diabetes Care · 2012 · PMC3402269 · PMID 22699287

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

On the other hand, the improvement in insulin sensitivity failed to reach statistical significance.

also in 6,035 other papers

did not reach statistical significanceno p-value reported

The decrease from baseline in mean glycated hemoglobin in the high-dose group (0.3, 1.0, and 3.0 mg/kg) did not reach statistical significance after 1, 2, or 3 months, respectively, consistent with the U-shaped dose-response curve.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.